Skip to main content
Veterinary Medicines

CARPRODYL QUADRI 50 MG TABLETS FOR DOGS

Authorised
  • Carprofen

Product identification

Medicine name:
CARPRODYL QUADRI 50 MG TABLETS FOR DOGS
Carprodyl Quadri, 50 mg, tableta za pse
Active substance:
  • Carprofen
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carprofen
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:
  • Cardboard box with 2 blisters of 10 tablets
  • Cardboard box with 50 blisters of 10 tablets
  • Cardboard box with 40 blisters of 10 tablets
  • Cardboard box with 30 blisters of 10 tablets
  • Cardboard box with 20 blisters of 10 tablets
  • Cardboard box with 10 blisters of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/24-01/800
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0172/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 18/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."